Sridevi Rajeeve
12PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve
|Nov 02, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma.Eric Jurgens, Tala Shekarkhand, Colin Rueda
|Oct 13, 2025
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma.Tara Sebastian, Sridevi Rajeeve, Tasmin Farzana
|Sep 16, 2025
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.Issam S Hamadeh, Lisa Modelevsky, Amelia Chan
|Aug 25, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.Ross S Firestone, Anish K Simhal, Devin McAvoy
Pageof 2
Frequent Collaborators
9 joint publications
Carlyn Rose Tan
9 joint publications
Kylee Maclachlan
9 joint publications
Urvi Shah
9 joint publications
Malin L Hultcrantz
8 joint publications
Sergio Giralt
8 joint publications
Neha Korde
8 joint publications
Heather Landau
7 joint publications
Hani Hassoun
7 joint publications
Sham Mailankody
7 joint publications
Saad Z Usmani
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
